MELANOMA (SKIN)
Clinical trials for MELANOMA (SKIN) explained in plain language.
Never miss a new study
Get alerted when new MELANOMA (SKIN) trials appear
Sign up with your email to follow new studies for MELANOMA (SKIN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New virus therapy aims to boost immune attack on hard-to-treat cancers
Disease control Recruiting nowThis early-phase study tests a new treatment called PeptiCRAd-1, a virus designed to train the immune system to attack cancer cells, combined with the immunotherapy drug pembrolizumab. About 15 adults with certain advanced solid tumors (like melanoma, lung cancer, or sarcoma) wil…
Matched conditions: MELANOMA (SKIN)
Phase: PHASE1 • Sponsor: Valo Therapeutics Oy • Aim: Disease control
Last updated May 26, 2026 03:14 UTC
-
New hope for hard-to-treat melanoma? drug combo trial launches
Disease control Recruiting nowThis study tests whether combining two drugs—cyclophosphamide and pembrolizumab—can shrink tumors in people with advanced melanoma that no longer responds to standard immunotherapy. About 14 adults with stage III or IV melanoma will receive the combination. The goal is to see if …
Matched conditions: MELANOMA (SKIN)
Phase: PHASE2 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated May 26, 2026 03:03 UTC
-
New drug duo targets brain tumors in advanced melanoma
Disease control Recruiting nowThis study tests whether combining two drugs, nivolumab and relatlimab, can help control melanoma that has spread to the brain. About 30 adults with active brain metastases will receive the combination and be monitored for safety and tumor response. The goal is to find a better t…
Matched conditions: MELANOMA (SKIN)
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New hope for Hard-to-Treat cancers: first human trial launches
Disease control Recruiting nowThis study tests a new drug called HMBD-501 in people with advanced melanoma, lung, or breast cancers that have stopped responding to standard treatments. The goal is to find a safe dose and see if the drug can shrink tumors. About 180 adults will take part in two phases: first t…
Matched conditions: MELANOMA (SKIN)
Phase: PHASE1, PHASE2 • Sponsor: Hummingbird Bioscience • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Exercise and fiber may boost immunotherapy in melanoma patients
Disease control Recruiting nowThis study looks at whether high-intensity exercise and a high-fiber diet are possible and helpful for people with advanced melanoma who are receiving immunotherapy. The goal is to see if these lifestyle changes can improve gut health and immune function. The study will involve 4…
Matched conditions: MELANOMA (SKIN)
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:49 UTC
-
Scientists probe Melanoma's metabolic tricks to outsmart immunotherapy
Knowledge-focused Recruiting nowThis study looks at how melanoma tumors change their metabolism to resist immunotherapy drugs like anti-PD1. Researchers will compare tumor samples from 20 patients whose cancer responds to treatment versus those whose cancer does not. The goal is to find new ways to target cance…
Matched conditions: MELANOMA (SKIN)
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated May 26, 2026 03:10 UTC